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Spider venoms contain a plethora of insecticidal peptides that act on neuronal ion channels and 
receptors. Due to their high specificity, potency, and stability these peptides have attracted much 
attention as potential environmentally-friendly insecticides. Although many insecticidal spider-
venom peptides have been isolated, the molecular target, mode of action and structure of only a 
small minority have been explored. Sf1a, a 46-residue peptide isolated from the venom of the 
tube-web spider Segesteria florentina, is insecticidal to a wide range of insects but non-toxic to 
vertebrates. In order to investigate its structure and mode of action, we developed an efficient 
bacterial expression system for production of Sf1a. We determined a high-resolution solution 
structure of Sf1a using multidimensional 3D/4D NMR spectroscopy. This revealed that Sf1a is a 
knottin peptide with an unusually large β-hairpin loop that accounts for a third of the peptide 
length. This loop is delimited by a fourth disulfide bond that is not commonly found in knottin 
peptides. We showed, through mutagenesis, that this large loop is functionally critical for 
insecticidal activity. Sf1a was further shown to be a selective inhibitor of insect voltage-gated 
sodium channels, consistent with its ‘depressant’ paralytic phenotype in insects. However, in 
contrast to the majority of spider-derived sodium channel toxins that function as gating modifiers 
via interaction with one or more of the voltage-sensor domains, Sf1a appears to act as a pore 
blocker.  
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1. Introduction  
Despite intensive control measures, herbivorous insects reduce world crop yields by 10–14% and 
damage as much as 30% of stored grain [1, 2]. Insects also vector a wide range of human diseases 
including malaria, dengue, and Chagas disease [3]. Half of the world's population is at risk of 
contracting insect-borne diseases[4], with malaria alone causing ~3000 deaths/day [5]. 
 
Chemical insecticides are the primary method of controlling insect pests [6]. Although there 
appears to be a vast array of extant chemical insecticides, there are in fact only a few major 
classes that act on a very small number of molecular targets in the insect nervous system [4, 7, 8]. 
These conditions have promoted the evolution of insecticide resistance, with more than 1000 
arthropod species now resistant to one or more classes of chemical insecticide [9]. The evolution 
of insecticide resistance has led to the withdrawal of chemical insecticides that are no longer 
considered effective, while concerns about the adverse impact of certain classes of chemical 
insecticides on the environment and human health has also led to widespread de-registrations and 
use cancellations by regulatory authorities [8]. These developments, along with more stringent 
requirements for registration of new insecticides, have significantly reduced the number of 
available insecticides [8]. For example, over the period 2005–2009 the U.S. Environmental 
Protection Agency (EPA) de-registered or limited the use of 169 insecticides while only 9 new 
insecticides were registered [4]. Thus, we are being forced to combat an increasing insect-pest 
problem with a rapidly diminishing chemical arsenal, resulting in an urgent need to discover new 
and safe insecticidal compounds. 
 
The success of transgenic plants expressing insecticidal Cry toxins from the bacterium Bacillus 
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thuringiensis has created a renewed interest in protein- and peptide-based insecticides [10]. 
Along with predatory beetles, spiders are the most successful insect predators on the planet and 
their venoms are replete with insecticidal peptide toxins [8, 11]. Remarkably, the venom of a 
single spider can contain as many as one thousand unique peptides [12, 13]. Although the EPA 
recently approved a spider-venom peptide for use as an insecticide 
(http://www.vestaron.com/epa-approval), very few insecticidal spider toxins have been 
sufficiently characterized to warrant consideration as bioinsecticides [8]. One promising 
candidate is SFI1 (U2-segestritoxin-Sf1a, hereafter Sf1a), a 46-residue peptide isolated from the 
venom of the tube-web spider Segestria florentina [14]. When injected into tobacco budworms 
(larvae of the noctuid moth Heliothis virescens), Sf1a induced flaccid paralysis within 15 min 
and killed larvae within 24 h, with an LD50 of 10 µg/g (~2 nmol/g) [14]. Moreover, Sf1a did not 
induce toxic effects in mice when injected intravenously at a dose of 1.5 mg/kg (~300 pmol/g). 
 
Since spiders inject venom into prey via hypodermic-needle-like fangs, there is no evolutionary 
selection pressure for spider toxins to be orally active. Although some insecticidal spider-venom 
peptides are orally active [15, 16] this is not the case for Sf1a [17]. However, the oral activity of 
Sf1a can be markedly improved by fusion to the plant lectin GNA (Galanthus nivalis agglutinin), 
which ferries attached peptide toxins across the gut epithelium via transcytosis and effectively 
delivers them to the hemocoel, Malpighian tubules, fat bodies, ovarioles, and central nervous 
system [18-20]. Using this approach, Sf1a was found to be highly insecticidal when fed to a 
range of insects, including the tomato moth Lacanobia oleracea [17], the peach-potato aphid 
Myzus persicae [21] and the rice brown planthopper Nilaparvata lugens [21]. 
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The structure and mode of action of Sf1a remain unknown. Here, we describe the development of 
an efficient E. coli expression system for production of Sf1a for structural and functional studies. 
We show that recombinant Sf1a is insecticidal to sheep blowflies (Lucilia cuprina) and we 
demonstrate that it acts by inhibiting insect voltage-gated sodium (NaV) channels and not voltage-
gated calcium (CaV) channels as initially suggested based on sequence homology. Moreover, we 
demonstrate that Sf1a inhibits insect NaV channels by blocking the pore of the channel and not by 
the more typical allosteric voltage-dependent mechanism reported for other spider toxins that act 
as gating-modifiers [14]. The three-dimensional (3D) solution structure of Sf1a that we 
determined using multidimensional heteronuclear NMR spectroscopy revealed that it contains an 
inhibitor cystine knot (ICK) motif that is commonly observed in spider-venom peptides [8, 22, 
23]. However, Sf1a contains an unusually large and disordered b-hairpin loop that is stabilized by 
an atypical fourth disulfide bond that anchors the ends of the loop. We show that this large b-




2.1 Production of recombinant Sf1a 
Recombinant production of venom peptide toxins is often challenging due to presence of multiple 
disulfide bonds, which cannot be formed in the cytoplasm of most prokaryotic and eukaryotic 
cells due to the reducing intracellular environment. An approach that has proved successful for 
expression of disulfide-rich spider toxins is production in the periplasm of E. coli, where the 
enzymes involved in disulfide-bond formation are located [24]. Thus, to produce Sf1a, we 
employed an isopropyl-β-D-thiogalactopyranoside (IPTG)-inducible construct (Fig. 1A) that 
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allowed export of a His6-MBP-toxin fusion protein to the E. coli periplasm. Using this expression 
system, a significant amount of His6-MBP-toxin fusion protein (>5 mg/litre) was recovered in the 
soluble cell fraction following IPTG induction. The native toxin was recovered after cleavage of 
the His6-MBP-Sf1a fusion protein using tobacco etch virus (TEV) protease. The initial construct, 
however, yielded a very small amount of cleaved product due to the native N-terminal Lys 
residue, which is not one of the preferred residues for the P1' position of TEV protease [25]. To 
improve the yield of cleaved protein, a non-native Ser residue, one of the two most preferred P1' 
residues for TEV protease, was added to the N-terminus of Sf1a. This recombinant Sf1a (referred 
to hereafter as rSf1a) was found to be equipotent with the initial construct having the native 
sequence and adopted the same tertiary fold as assessed by 1D 1H NMR. Thus, this construct was 
used in all subsequent experiments. However, the amino acid residue numbering used throughout 
this article is for the native sequence.  
 
The His6-MBP-rSf1a fusion protein was purified using nickel affinity chromatography (Fig 1C, 
lanes 1–4). There was minimal loss of fusion protein in the flow through from the Ni-NTA beads 
(Fig. 1C, lanes 5–6). The bound fusion protein was eluted from the column and cleaved with 
His6-tagged TEV protease (Fig. 1C, lanes 7–8). The His6-tagged MBP and TEV protease were 
then removed by passage through a solid-phase extraction (SPE) column (Fig. 1D), and rSf1a 
subsequently purified using reverse-phase (RP) HPLC. rSf1a eluted as a single major disulfide-
bond isomer with a retention time of ~25 min under the chosen experimental conditions. The 
purity of rSf1a was assessed to be >98% as judged by SDS-PAGE and matrix-assisted laser-
desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) (Fig. 1D, inset). The 
final yield of rSf1a was ~2 mg of toxin per litre of culture.  
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2.2 rSf1a is lethal to insects 
Depending on the dose, rSf1a induced uncoordinated movements within 5–10 min following 
injection into sheep blowflies (L. cuprina) and full paralysis within 15–60 min. Flies remained 
paralysed until 24 h when final paralysis statistics were recorded. Despite being almost 
completely paralysed and unable to make whole-body movements, flies still showed minor 
movements of the proboscis or extremities, even when injected with the highest doses of Sf1a. 
Lethality at 24 h remained below 20%. The median paralytic dose (PD50) values for native Sf1a 
and rSf1a were determined to be 2.2 ± 0.2 nmol/g and 1.5 ± 0.3 nmol/g, respectively, which were 
not significantly different (unpaired t-test, n = 3, p > 0.05).  
 
2.3.1 rSf1a is a NaV channel pore blocker 
We first investigated whether rSf1a modulated the activity of insect NaV channels. Whole-cell 
sodium currents (INa) were recorded from dorsal unpaired median (DUM) neurons isolated from 
the American cockroach Periplaneta americana. The voltage-clamp configuration was used and 
depolarizing test pulses to –10 mV from a holding potential (Vh) of –90 mV (Fig. 2Ba) were 
employed to elicit fast activating and inactivating inward INa. During a 5-min perfusion, 1 µM 
rSf1a caused rapid inhibition of peak INa amplitude (55.7 ± 6.2% block of control peak INa, p < 
0.05, n = 4; Fig. 2A,E) that was only partially reversible (~25% recovery) after prolonged 
washout in toxin-free solution. Interestingly, even a very high rSf1a concentrations (10 µM) 
failed to completely block INa (60.0 ± 5.0% block of control peak INa, p < 0.05, n =3; Fig. 2C) 
while 300 nM rSf1a failed to produce significant inhibition (7.0 ± 0.6% block of control peak INa, 
p > 0.05, n = 11; Fig. 2D). At both 1 and 10 µM, rSf1a failed to alter the kinetics of NaV channel 
activation or inactivation (Fig. 2A,C). To test if a series of depolarizing pulses could cause 
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dissociation of the toxin, post-pulses to +140 mV were applied immediately following a test 
pulse to –10 mV from a Vh of –90 mV (Fig. 2Bb). However, the depolarizing post-pulses failed to 
cause any significant relief from the fractional block of INa by 1 µM rSf1a compared with 
currents recorded in the absence of rSf1a (p > 0.05, n = 5; Fig. 2F). 
 
To investigate whether rSf1a-induced inhibition of peak INa was due to a depolarizing shift in the 
voltage dependence of NaV channel activation, peak INa amplitude was tested as a function of 
membrane potential (INa-V). Families of INa were elicited using a test pulse (Vtest) that depolarized 
the cell from a Vh of –90 mV to +70 mV for 50 ms in 10-mV increments (Fig. 3A) before 
(Fig.  3C), and after (Fig. 3D), application of 1 µM rSf1a. Peak INa were then normalized against 
the maximum peak INa in the control and plotted against membrane potential (Vm) to establish an 
INa-V curve. Peak INa were then fitted to Eq. 1 (see Section 2.8) using non-linear regression 
analysis (Fig. 3E). In the absence of toxin, INa activated at around –50 mV, which did not shift in 
the presence of rSf1a (Fig. 3E). The voltage at half maximum NaV channel activation (V0.5) in 
control cells was only marginally shifted (1.4 mV) in the depolarizing direction in the presence of 
1 µM rSf1a (control: V0.5 = –21.4 ± 1.3 mV; slope factor = 5.1 ± 1.0 versus toxin: V0.5 = –20.0 ± 
1.1 mV; slope factor = 5.4 ± 0.8; n = 4, p > 0.05; Fig. 3E). This is more clearly observed as a lack 
of any significant shift in the voltage dependence of activation when currents recorded in the 
presence of toxin were normalized to the peak inward INa in the presence of toxin (Fig. 3F). This 
also revealed that the inhibition of NaV channels by 1 µM rSf1a was voltage-independent and the 
binding of the toxin to the channel was not relieved at increasing membrane potentials, 
supporting the finding of the experiments using depolarizing post-pulses.  
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The effects of rSf1a on the voltage dependence of steady-state NaV channel inactivation (h∞-V) 
was also examined to determine whether the reduction of peak INa was due to stabilization of the 
inactivated (closed) state of the channel, and hence a reduction in channel availability, as opposed 
to a pore blocking mechanism. Accordingly, experiments were conducted using a two-pulse 
protocol that utilized a 1-s conditioning prepulse (Vprepulse) from –120 mV to 0 mV in 10-mV 
increments, followed by a 50-ms test pulse (Vtest) to –10 mV (Fig. 3B). In the presence of 1 µM 
rSf1a, INa were inhibited to 51 ± 2% (n = 3) of control peak amplitude (parameter ‘A’ in Eq. 2; 
Fig. 3G). Normalization of the toxin data to the maximum peak INa in the presence of toxin 
revealed that the curves almost completely overlap (Fig. 3H) with no significant shift in h∞-V 
(control: V0.5 = –33.8 ± 0.3 mV and toxin: V0.5 = –35.5 ± 0.8 mV: p > 0.05, n = 3; Fig. 3H). Thus, 
the 49% reduction in INa does not appear to be the result of a reduction in NaV channel 
availability due to stabilization of the channels in the closed-inactivated state. Thus, rSf1a 
appears to be a NaV channel pore blocker. 
 
2.3.2 rSf1a has no significant effect on CaV or KV channels 
Given that NaV channel-targeting spider toxins may also interact with CaV channels [26], we 
tested the ability of rSf1a to modulate the activity of insect CaV channels. At least two subtypes 
of CaV channel currents have been demonstrated in cockroach DUM neurons, including high-
voltage-activated (HVA) and mid/low-voltage-activated (M-LVA) CaV channel currents [27-30]. 
Unfortunately, despite differences in the kinetic and pharmacological properties of M-LVA and 
HVA CaV channel currents, there remains no mechanism for recording one current in isolation 
from the other as no peptide or organic blockers are available that exclusively block one type of 
current [27]. As previously described, depolarizing voltage command pulses to different levels 
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were used to investigate actions on M-LVA and HVA CaV channels, respectively [30-32]. CaV 
channel barium currents (IBa) were evoked by 50-ms depolarizing pulses from a Vh of –90 mV at 
7-s intervals to –30 mV for generation of predominantly M-LVA CaV channel currents and to +20 
mV to evoke mainly HVA CaV channel currents (Fig. 4Ca) [27, 30]. Depolarizations to –30 mV 
caused an inward IBa with slow inactivation, consistent with a reduction in Ca2+-dependent fast 
inactivation due to the use of Ba2+ as the charge carrier [27], whereas depolarizations to +20 mV 
elicited a smaller IBa with a faster inactivating component (Fig. 4A,B). Following a 5-min 
perfusion, 1 µM rSf1a caused only weak inhibition of both M-LVA and HVA CaV channel 
currents. The M-LVA CaV channel currents were reduced by 31.5 ± 44.0.% (p > 0.05, n = 5) and 
HVA CaV channel currents by 11.5 ± 9.7% (p > 0.05, n = 5). There were also no significant 
changes in M-LVA and HVA IBa activation and inactivation kinetics (Fig. 4A,B). 
 
To investigate whether there was any shift in the threshold of CaV channel activation, IBa-V 
relationships were established from families of IBa generated by 100-ms depolarizing test 
potentials from Vh of –90 mV to +40 mV, at 10-mV increments every 7 s (Fig. 4Cb). Families of 
peak inward IBa were normalized against the maximum control inward peak IBa and plotted 
against the membrane potential. In controls, DUM neuron CaV channels activated between –50 
mV and –40 mV. In the presence of 1 µM rSf1a this threshold was shifted slightly in the 
hyperpolarizing direction (Fig. 4D). This may be the cause of the large variance in the magnitude 
of inhibition of M-LVA CaV channel currents, detailed above. However, there was no significant 
shift in the V0.5 of channel activation (control: V0.5 = –29 ± 1 mV versus toxin: V0.5 = –27 ± 1 mV; 
n = 5, p > 0.05) and currents were essentially superimposable when the toxin data was 
normalized to the maximum peak IBa in the presence of toxin (dotted line, Fig. 4D). 
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For completeness, we also determined the effect of rSf1a on the major outward KV channel 
current subtypes present in cockroach DUM neurons. These include a slowly activating delayed-
rectifier [IK(DR)], transient ‘A-type’ [IK(A)], and large-conductance Ca2+-activated [IBK(Ca)] voltage-
gated  potassium (KV) channel currents [33]. To determine the effects of 1 µM rSf1a on KV 
channels, global KV channel currents (IK) were generated by 50-ms depolarizing test pulses to 
+30 mV from a Vh of –80 mV, every 5 s (Fig. 4Fa). Global IK were measured at the peak (circles) 
and at the end of the test pulse (50 ms, squares). The early peak global IK results mainly from the 
contribution of rapidly activating IK(A) and IBK(Ca), while the late global IK results from the slowly 
activating IK(DR) and slow inactivating component of the IBK(Ca). Application of 1 µM rSf1a caused 
a non-significant inhibition of outward global IK reducing the peak global IK by 18 ± 15% and the 
late global IK by 18 ± 13% (p > 0.05 in both cases, n = 3; Fig. 4E). This lack of overt activity was 
mirrored by the lack of effect on the voltage-dependence of global IK activation. Global IK-V 
relationships generated by the pulse protocol shown in Fig. 4Fb were not significantly altered, 
with no marked differences in V0.5 values between the IK-V for controls (V0.5 = –5 ± 2 mV for 
early and –8 ± 4 mV for late IK) versus toxin (V0.5 = –7 ± 3 mV for early and –8 ± 4 mV for late 
IK) (p > 0.05; n = 3; Fig. 4G-H). Currents were essentially superimposable when the toxin data 
was normalized to maximum peak global IK in the presence of toxin (dotted lines, Figs. 4G-H). 
 
2.4 High-resolution solution structure of rSf1a 
Buffer conductivity and pH can have a pronounced effect on NMR spectra and thus several 
conditions were screened to optimize NMR data quality, including 20 mM phosphate buffer, pH 
6; 20 mM MES buffer, pH 6; 20 mM acetate buffer, pH 5; 20 mM citrate buffer pH 4.0; and 
20 mM citrate buffer, pH 3.5. These buffer screens revealed that the sidechain of Trp33 exists in 
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several stable conformations and that the population of the minor conformations was reduced at 
low pH and high temperature. Trp33 is adjacent to Pro32 and therefore cis-trans isomerization of 
the Arg31-Pro32 peptide bond might be responsible for the observed conformational isomerism 
[34]. Such conformational dynamics are known to be both temperature and pH dependent [35]. 
 
Consequently, NMR data were collected at 40˚C using 13C/15N-labelled rSf1a dissolved in 
20 mM citrate buffer, pH 3.5. 1HN, 15N, 13Cα, 13Cβ, and 13C resonance assignments were obtained 
from analysis of amide-proton strips in 3D HNCACB, CBCA(CO)NH, and HNCO spectra. 
Sidechain 1H and 13C chemical shifts were obtained using a 4D HCC(CO)NH-TOCSY 
experiment, which has the advantage of providing sidechain 1H-13C connectivities [36]. A fully 
assigned 1H-15N HSQC spectrum of rSf1a is shown in Fig. 5. Complete chemical shift 
assignments have been deposited in BioMagResBank (Accession Number 19535). 
 
CYANA was used for automated NOESY assignment and structure calculation [37]. Disulfide-
bond connectivities were determined from 15N and 13C NOESY spectra and confirmed by 
performing structure calculations without inclusion of disulfide-bond restraints. The following 
connectivities were unambiguously established following this procedure: Cys3-Cys19, Cys10-
Cys22, Cys18-Cys42, and Cys24-Cys40, which corresponds to a 1–4, 2–5, 3–8, 6–7 framework, 
as described previously for Aps III [8]. For structure calculations, interproton distance restraints 
were supplemented with 75 dihedral-angle restraints (36 f, 39 ψ) derived from TALOS+ 
chemical shift analysis [38]. 200 structures were calculated from random starting conformations, 
then the 20 structures with the lowest target function values were selected to represent the 
solution structure of rSf1a. Coordinates for the final ensemble of structures have been deposited 
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in the Protein Data Bank (Accession Number 2MF3). 
 
The final ensemble of structures revealed that Sf1a contains a canonical ICK motif [39] (Fig. 6A) 
in which the Cys10-Cys22 and Cys3-Cys19 disulfide bonds and the intervening section of the 
peptide backbone form a ring that is pierced by the Cys18-Cys42 disulfide bond (Fig. 6B). The 
Cys24-Cys40 disulfide acts as a “molecular staple” to hold together the ends of the extended b-
hairpin loop. This loop was poorly defined in the calculated structures and analysis of random 
coil indices by TALOS+ clearly shows that this loop is disordered (S2 ~0.65 compared to average 
of ~0.8 for the core of the molecule). When the disordered hairpin loop and N-terminal residues 
are excluded, the ensemble of 20 structures overlay very well, with backbone and heavy-atom 
RMSDs of 0.13 Å and 0.43 Å, respectively, over residues 4–26 and 39–45. Based on precision 
and Ramachandran plot quality (see Table 1), the structure ranks as high resolution [40]. The 
structure has high stereochemical quality with a mean MolProbity [41] score of 1.55 ± 0.18, 
placing it in the 93rd percentile relative to other protein structures. 
 
A search for structural homologs [42] revealed that rSf1a has similar topology to numerous other 
spider toxins containing the ICK motif. However, this search also revealed close structural 
homology to tachystatin B (PDB 2DCV), an antimicrobial ICK-containing peptide isolated from 
the Japanese horseshoe crab Tachypleus tridentatus [43]. Tachystatin B does not contain the 
extended hairpin loop found in rSf1a but the two peptides overlay well over their core ICK 
regions (Fig. 6C). A similarly large hairpin loop is present in the structure of the insecticidal 
spider-venom peptide Aps III (µ-CUTX-As1a) [8]. In Aps III this loop is comprised of 14 
residues, which is larger than found in typical ICK peptides but significantly shorter than the 19-
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residue loop present in rSf1a. An overlay of the structures of rSf1a and Aps III reveals that the 
placement of the non-ICK disulfide bond is very different in the two peptides (Fig. 6C). 
 
2.5 Functional importance of the b-hairpin loop 
The b-hairpin loop in spider-venom ICK peptides often houses functionally critical residues [7]. 
The unusually large b-hairpin loop found in Sf1a contains an Arg-Pro-Trp (RPW) motif that is 
strictly conserved in this family of toxins [14] and we therefore wondered whether this motif 
might be critical for the toxin's insecticidal activity.  
 
We produced a mutant of rSf1a in which residues R31 and W33 were both replaced with alanine. 
The mutant peptide (rSf1a-R31A/W33A) was purified and characterized as described above for 
rSf1a and shown to adopt the same fold as the native peptide by comparison of their 2D 1H-15N 
HSQC spectra. In striking contrast to rSf1a (PD50 = 1.5 nmol/g), the R31A/W33A double mutant 
was not insecticidal to blowflies at doses up to 95.4 nmol/g (i.e. there were no signs of paralysis 
or lethality up to 24 h after injection). Moreover, at a concentration of 1 µM, the rSf1a-
R31A/W33A mutant failed to significantly inhibit INa in DUM neurons (5.9 ± 1.8% block of 
control peak INa, p > 0.05, n = 3; Fig. 2D), consistent with its lack of insecticidal activity. We 
therefore conclude that the b-hairpin loop, and in particular the conserved RPW motif, is critical 
for the activity of Sf1a. 
 
3. Discussion 
3.1 Molecular target of Sf1a 
We examined the effect of rSf1a on insect NaV, CaV and KV channels that represent common 
	 15	
targets for insecticidal spider toxins. The main effect of rSf1a was to produce a rapid, but 
incomplete, block of insect NaV channels that occurred in the absence of: (i) a shift in the voltage 
dependence of activation; (ii) a shift in the voltage dependence of steady-state inactivation; or 
(iii) depolarization-induced dissociation of binding. Furthermore, Sf1a failed to modulate the 
gating or kinetics of NaV channel currents and the inhibition of INa was not relieved by 
depolarizing pulses. We also showed that rSf1a does not significantly affect the activity of insect 
CaV channels nor delayed-rectifier, ‘A-type’ or BKCa potassium channels that are the major 
contributors to the global outward Kv channel current in cockroach DUM neurons. Thus, rSf1a 
appears to be a channel blocker that selectively plugs the outer vestibule of NaV channels in a 
manner similar to µ-conotoxins [45]. The incomplete block of Na+ flux induced by rSf1a is 
consistent with the toxin binding to the channel outer vestibule rather then lodging deep into the 
pore region and causing complete steric block of the insect NaV channel pore. [44]. 
 
Most other NaV channel blockers isolated from spider venoms act as ‘gating-modifiers’ that 
reduce INa by causing a depolarizing shift in the voltage-dependence of NaV channel activation, 
thereby inducing a flaccid or ‘depressant’ phenotype. This results from an interaction with one, or 
more, of the four NaV channel voltage sensors [46]. These spider toxins include the depressant 
theraphotoxins β-TRTX-Cm1a, -Cm1b and Cm2a (ceratotoxin-1, -2 and -3) from Ceratogyrus 
marshalli and β-theraphotoxin-Ps1a from Paraphysa scrofa [47]. In contrast, rSf1a inhibits insect 
NaV channel conductance in the absence of any depolarizing shift in the voltage-dependence of 
activation. Given this distinct lack of any voltage-dependent shift in channel activation, Sf1a 
belongs to a growing group of spider µ-toxins that appear to occlude the outer vestibule of the 
insect NaV channel. This includes Aps III (µ-CUTX-As1a) from the unrelated spider Apomastus 
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schlingeri [8]. Unlike Aps III, which acts on both Nav and to a lesser extent Cav channels, rSf1a 
selectively blocks insect Nav channels. Furthermore, Sf1a is marginally more potent than two 
other µ-theraphotoxins that are pore-blockers: µ-TRTX-Hhn2b (hainantoxin-I) and µ-TRTX-
Hh1a (huwentoxin-III) from two different species of Chinese Haplopelma tarantulas. These two 
toxins block insect NaV channels presumably via binding to neurotoxin receptor site-1 near the 
mouth of the channel with IC50 concentrations for block of the channel between 1.1 and 4.5 µM 
[48, 49]. While the IC50 for Sf1a on insect NaV channels was not definitively determined in the 
present study, it is <1 µM as this concentration caused a 60% block of cockroach DUM neuron 
INa. Thus, although both µ-TRTX-Hhn2b and µ-TRTX-Hh1a selectively inhibit insect NaV 
channels, rSf1a targets the insect NaV channel with higher affinity, consistent with its modest, but 
irreversible, depressant paralytic activity (PD50 = 1.5 nmol/g). 
 
An additional mechanism that can lead to an inhibition of INa is a decrease in NaV channel 
availability, as observed with µ-TMTX-Hme1a from venom of the spider Heriaeus melloteei 
[50]. This mechanism of action causes an increase in the number of NaV channels stabilized in 
the closed-inactivated state as observed by a hyperpolarizing shift in the voltage-dependence of 
steady-state inactivation. In contrast to µ-TMTX-Hme1a, rSf1a failed to produce any significant 
hyperpolarizing shift in the voltage-dependence of steady-state NaV channel inactivation lending 
further support to the notion that the toxin occludes the outer vestibule of the channel. 
 
Finally, voltage-dependent dissociation of bound toxins from mammalian and insect NaV 
channels has also previously been demonstrated with a range of spider, scorpion and sea anemone 
toxins [51-55]. However, there was no indication of voltage-dependent dissociation of rSf1a from 
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DUM neurons using depolarizing post-pulse protocols. 
 
In summary, rSf1a inhibits NaV channels via partial block of the channel pore. This inhibition 
occurs in the absence of any alteration to the kinetics of NaV channel inactivation as observed for 
spider δ-toxins [56] and Sf1a fails to produce any hyperpolarizing shift (as seen for excitatory β-
toxins [57]) or a depolarizing shift (as observed for depressant β-toxins [58]) in the voltage-
dependence of NaV channel activation. Based on the pharmacology described here, rSf1a should 
be renamed µ-segestritoxin-Sf1a (µ-SGTX-Sf1a) based on the rational nomenclature recently 
proposed for spider-venom peptides [59]. This is consistent with its action to induce flaccid 
paralysis, in contrast with the spastic paralysis observed with spider δ-toxins [60] and excitatory 
β-toxins [61]. 
 
The incomplete block of NaV channels is unlikely to be the sole cause of Sf1a toxicity. Given the 
weak effects of Sf1a on neuronal calcium channels, an additional target might be the HVA-like 
dihydropyridine-sensitive CaV channels found on the surface of invertebrate skeletal muscle [28], 
which are critical for conduction of muscle action potentials. 
 
3.2 Unusual structure of Sf1a 
The ICK/knottin topology is by far the dominant structural scaffold found in spider venoms [8] 
and it is therefore not surprising to find that rSf1a conforms to this paradigm. Many spider-
venom knottins are elaborated with a fourth non-ICK disulfide bond such as the d-hexatoxins 
with 1–4, 2-6, 3–7, 5–8 connectivity [62] and the k-hexatoxins that contain a rare vicinal 
disulfide bond leading to 1–6, 2–7, 3–4, 5–8 connectivity [63, 64]. However, the 1–4, 2–5, 6–7, 
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3–8 disulfide connectivity seen in rSf1a is rare and has only been described for the following 
spider toxins: Aps III (PDB 2M36) [8], U2-hexatoxin-Hi1a (PDB 1KQH/1KQI) [34], w-agatoxin 
IVA (PDB 1IVA) [65], d-palutoxin IT2 (PDB 1V91) [66] and µ-agatoxin I (PDB 1EIT) [67]. In 
all these structures except for Aps III, the non-ICK disulfide bond delineates the boundaries of a 
4–6 residue loop, potentially as a mechanism for decoupling the dynamics of the loop from the 
ICK core. In Aps III the auxiliary disulfide bond appears to stabilise a dynamic glycine-rich 
segment within the loop [8]. Notably, in rSf1a this loop comprises 19 residues, making up a third 
of the entire peptide sequence, making it by far the largest such loop described for any ICK 
peptide in this class. Cis-trans isomerization of the Tyr29-Pro30 peptide bond in the loop region 
of U2-hexatoxin-Hi1a leads to an equilibrium between two equally populated conformers. In 
rSf1a, we observed multiple conformations of the tryptophan residue adjacent to Pro32, but the 
minor conformers made up a small fraction of the equilibrium population.  
 
The unusual b-hairpin loop in rSf1a was found to be functionally critical. Simultaneous mutation 
of R31 and W33 within the conserved RPW motif in the b-hairpin loop led to a mutant toxin that 
lacked insecticidal activity and was able to inhibit insect NaV channel currents. The only other 
peptide in this class of knottins for which the pharmacophore has been mapped is d-palutoxin IT2 
and in this case the b-hairpin loop was also found to be functionally important [66].  
 
Finally, we note that the second closest structural homolog of rSf1a is tachystatin B, an 
antimicrobial peptide isolated from the Japanese horseshoe crab Tachypleus tridentatus [43]. The 
two peptides overlay very closely over their core ICK regions, but deviate significantly over the 
unusually large disordered loop of rSf1a. The origin of the ICK fold remains under debate; there 
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is conflicting evidence about whether the ICK motif evolved from an ancestral two-disulfide, 
disulfide-directed β-hairpin (DDH) fold by addition of a disulfide bond [63, 69] or vice versa 
[70]. The presence of the ICK fold in an ancient marine arthropod suggests that the ICK fold may 
have already been present prior to its recruitment into the venom of arthropods. In this scenario, 
the ICK fold would be the plesiotypic state with the DDH fold subsequently evolving via loss of 
a disulfide bond. This would provide an alternative explanation for the rarity of DDH peptides in 
arachnid venoms [69].  
 
3.3 Sf1a as a bioinsecticide  
We found that Sf1a caused a long-lasting, irreversible paralysis in sheep blowflies that eventually 
led to death by starvation. Due to methodological issues (i.e. high mortality in controls beyond 
24 h), we could not determine the PD50 at longer time periods. However, flies paralysed by high 
doses of rSf1a remained paralysed 48 h after injection The observed effects of rSf1a in blowflies 
are similar to those recently reported for the spider-venom peptide Aps III, although Aps III is 3-
fold more potent with a PD50 of 700 pmol/g [8]. Given the observed insecticidal effects of rSf1a 
in blowflies, it seems likely that it would produce similar effects in dipteran pests such as 
mosquitoes and tsetse flies that vector human diseases. Since rSf1a is also active against 
lepidopteran [14, 17] and hemipteran [21] pests, but inactive against vertebrates [14], it appears 
to be a suitable lead for development of novel bioinsecticides [4]. Although the moderate potency 
of Sf1a would require large amounts to be applied in the field for efficient pest control, delivery 
of the toxin to pest insects via genetic engineering of crops or via insect-specific pathogens (e.g., 
entomopathogenic fungi) might provide efficient delivery of the toxin at effective concentrations.  
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In summary, we have shown that Sf1a is a NaV channel-specific insecticidal toxin that acts via a 
non-voltage dependent mechanism. This is an atypical mode of action that has previously only 
been observed in one other spider toxin, namely Aps III. Although less potent than Aps III, the 
specificity of Sf1a towards NaV channels makes it an attractive pharmacological tool.  
  
	 21	
4. Material and Methods 
4.1. Chemicals  
All chemicals were purchased from Sigma-Aldrich Australia (Castle Hill, NSW, Australia), 
Sigma-Aldrich USA (St Louis, MO, USA), or Merck Chemicals (Kilsyth, Victoria, Australia) 
with the exception of IPTG (Life Technologies, Victoria, Australia) and HPLC-grade acetonitrile 
(RCI Labscan, Bangkok, Thailand). 13C6-glucose and 15NH4Cl were purchased from Sigma-
Aldrich Australia. Recombinant His6-TEV protease (EC 3.4.22.44) was produced in-house using 
a previously described protocol [71]. 
 
4.2 Nomenclature 
Based on the rational nomenclature proposed for spider-venom peptides [59], SFI1 should be 
renamed µ-segestritoxin-Sf1a (µ-SGTX-Sf1a) based on its source and activity on NaV channels. 
 
4.3 Production of recombinant Sf1a 
A synthetic gene encoding Sf1a, with codons optimized for expression in E. coli, was synthesized 
and cloned into the pLIC-MBP expression vector by GeneArt (Invitrogen, Regensburg, 
Germany). This vector (pLIC-NSB2), which was designed as described earlier [8], encodes an 
IPTG-inducible LacI promoter, a MalE signal sequence for periplasmic export, a His6 tag for 
nickel affinity purification, maltose-binding protein (MBP) fusion tag to enhance solubility, and a 
TEV protease cleavage site between the MBP and Sf1a coding regions (Fig. 1A). The plasmid 
was transformed into E. coli strain BL21(λDE3) for rSf1a production. Cultures were grown in 
Terrific Broth (TB) medium using baffled flasks at 37°C with shaking at 110 rpm. Expression of 
the toxin gene was induced with 1 mM IPTG at an OD600 of 0.9–1.0, then cells were grown at 
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18°C for a further 15 h and harvested by centrifugation for 12 min at 6000 rpm. For production of 
uniformly 13C/15N-labelled Sf1a, cultures were grown in minimal medium supplemented with 
13C6-glucose and 15NH4Cl as the sole carbon and nitrogen sources, respectively. 
 
The His6-MBP-rSf1a fusion protein was extracted from the bacterial periplasm by cell disruption 
at 27 kPa (TS Series Cell Disrupter, Constant Systems Ltd, Northants, UK), then captured by 
passing the periplasmic extract (buffered in 40 mM Tris, 450 mM NaCl, pH 8.0) over Ni-NTA 
Superflow resin (Qiagen) followed by washing with 10 mM imidazole to remove any products 
that bound non-specifically to the resin. The fusion protein was then eluted with 500 mM 
imidazole. The eluted fusion protein was concentrated to 5 ml and then the buffer was exchanged 
to remove imidazole. Reduced and oxidized glutathione were then added to 0.6 mM and 0.4 mM, 
respectively, to maintain TEV protease activity. Approximately 100 µg of His6-tagged TEV 
protease was added per mg of fusion protein, and then the cleavage reaction was allowed to 
proceed at room temperature for 12 h. The cleaved His6-MBP and His6-TEV were removed by 
using SPE columns; the mixtures was loaded onto the column and the peptide eluted with 40% 
elution solvent (Solvent B: 0.043% trifluoroacetic acid (TFA) in 90% acetonitrile). The eluate 
was lyophilized and then semi-pure rSf1a was subjected to further purification using RP-HPLC. 
RP-HPLC was performed on a Vydac C18 column (250 x 4.6 mm, particle size 5 µm) using a 
flow rate of 1 ml/min and a gradient of 20–40% Solvent B in Solvent A (0.05% TFA in water) 
over 20 min. 
 
4.4 MALDI-TOF mass spectrometry 
Peptide masses were determined using MALDI-TOF MS employing a Model 4700 Proteomics 
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Bioanalyser (Applied Biosystems, CA, USA). RP-HPLC fractions were mixed 1:1 (v:v) with α-
cyano-4 hydroxycinnamic acid matrix (5 mg/ml in 50/50 acetonitrile/H2O) and MALDI-TOF 
spectra were acquired in positive reflector mode. All reported masses are for monoisotopic 
[M+H]+ ions. 
 
4.5 Blowfly toxicity assay 
Insect toxicity assays were performed as described previously [8] Briefly, rSf1a, nat-Sf1a or 
rSf1a-R31A/W33A were injected into the ventro-lateral thoracic region of sheep blowflies 
(Lucilia cuprina) weighing 19.5–25.9 mg. Three separate experiments were conducted for each 
Sf1a homolog, each comprising 3–10 doses, with each dose injected into ten flies. Paralytic and 
lethal effects were measured 24 h post-injection. PD50 values were calculated as described 
previously [8] with statistical analysis and unpaired Student’s t-tests performed using Prism 6. 
 
4.6 Structure determination    
NMR spectra were acquired at 40°C on a 900 MHz NMR spectrometer (Bruker BioSpin, 
Germany) equipped with a cryogenically cooled probe. 15N/13C-labelled rSf1a was dissolved in 
20 mM citrate, pH 3.5 at a final peptide concentration of 420 µM, followed by addition 
of 5  D2O. The sample was filtered using a low-protein-binding Ultrafree-MC centrifugal 
filter (0.22 µm pore size; Millipore, MA, USA), then 300 µL was added to a susceptibility 
matched 5 mm outer-diameter microtube (Shigemi Inc., Japan).  
 
3D and 4D spectra used for resonance assignments were acquired using non-uniform sampling 
(NUS) [72]. Sampling schedules that approximated the signal decay in each indirect dimension 
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were generated using sched3D [36]. NUS data were processed using the Rowland NMR toolkit 
(www.rowland.org/rnmrtk/toolkit.html) and maximum entropy parameters were automatically 
selected as previously described [73]. 13C- and 15N-edited HSQC-NOESY spectra (mixing time of 
200 ms) were acquired using uniform sampling. Separate 13C-edit HSQC-NOESY spectra were 
acquired for the aliphatic and aromatic regions of the carbon spectrum. 
 
Dihedral angles were derived from TALOS+ chemical shift analysis [38] and the restraint range 
for structure calculations was set to twice the estimated standard deviation. NOESY spectra were 
manually peak picked and integrated, peak lists were then automatically assigned, distance 
restraints extracted, and an ensemble of structures calculated using the torsion angle dynamics 
package CYANA 3.0 [37]. The tolerances used for CYANA were 0.02 ppm in the direct 1H 
dimension, 0.04 ppm in the indirect 1H dimension, and 0.4 ppm for the heteronucleus (13C/15N). 
During the automated NOESY assignment/structure calculation process, CYANA assigned 92% 
of all NOESY crosspeaks (1447 out of 1566). The four disulfide bonds were assigned based on 
preliminary structure calculations; subsequent calculations included distance restraints for these 
disulfide bonds as described previously [74]. 
 
4.7 Electrophysiological measurements on insect neurons 
DUM neurons were isolated from unsexed adult American cockroaches (Periplaneta americana) 
as described previously [8]. Briefly, terminal abdominal ganglia were removed and placed in 
normal insect saline (NIS) containing (in mM): NaCl 180, KCl 3.1, N-hydroxyethylpiperazine-N-
ethanesulfonic acid (HEPES) 10 and D-glucose 20. Ganglia were then incubated in 1 mg/ml 
collagenase (type IA) for 40 min at 29°C. Following enzymatic treatment, ganglia were washed 
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twice in NIS and resuspended in NIS supplemented with 4 mM MgCl2, 5 mM CaCl2, 5% foetal 
bovine serum and 1% penicillin/streptomycin (Life Technologies, Victoria, Australia) (NIS+) and 
triturated through a fire-polished Pasteur pipette. The resultant cell suspension was then 
distributed onto 12-mm diameter glass coverslips pre-coated with 2 mg/ml concanavalin A (type 
IV). DUM neurons were maintained in NIS+ at 29°C and 100 % humidity. Ionic currents were 
recorded in voltage-clamp mode using the whole-cell patch-clamp technique, employing version 
10.2 of the pCLAMP data acquisition system (Molecular Devices, Sunnyvale, CA). Data were 
filtered at 5–10 kHz with a low-pass Bessel filter with leakage and capacitive currents subtracted 
using P–P/4 procedures. Digital sampling rates were set between 15 and 25 kHz depending on 
the length of the protocol. Single-use 0.8–2.5 MΩ electrodes were pulled from borosilicate glass 
and fire-polished prior to current recordings. Liquid junction potentials were calculated using 
JPCALC [75], and all data were compensated for these values. Cells were bathed in external 
solution through a continuous pressurized perfusion system at 1 ml/min, while toxin solutions 
were introduced via direct pressurized application using a perfusion needle at ~50 µl/min 
(Automate Scientific, San Francisco, CA). Control data were not acquired until at least 20 min 
after whole-cell configuration was achieved to eliminate the influence of fast time-dependent 
shifts in steady-state inactivation resulting in rundown of INa from NaV channels. All experiments 
were performed at ambient room temperature (20–23°C). To record INa, the external bath solution 
contained (in mM): NaCl 230, CsCl 5, CaCl2 1.8, tetraethylammonium chloride (TEA-Cl) 50, 4-
aminopyridine (4-AP) 5, HEPES 10, NiCl2 0.1, and CdCl2 1, adjusted to pH 7.4 with 1 M NaOH. 
The pipette solution contained (in mM): NaCl 34, CsF 135, MgCl2 1, HEPES 10, ethylene 
glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA) 5, and ATP-Na2 3, adjusted to 
pH 7.4 with 1 M CsOH. To eliminate any influence of differences in osmotic pressure, all internal 
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and external solutions were adjusted to 400 ± 5 mOsmol/l with sucrose. Due to the reported 
current rundown with calcium as a charge carrier [27], BaCl2 replaced CaCl2 in all experiments 
on voltage-gated CaV channels. The external bath solution for IBa recordings contained (in mM): 
Na acetate 140, TEA-Br 30, BaCl2 3 and HEPES 10, adjusted to pH 7.4 with 1 M TEA-OH. The 
external solution also contained 300 nM tetrodotoxin (TTX) to block NaV channels. Pipette 
solutions contained (in mM): Na acetate 10, CsCl 110, TEA-Br 50, ATP-Na2 2, CaCl2 0.5, EGTA 
10 and HEPES 10, adjusted to pH 7.4 with 1 M CsOH. The external bath solution for recording 
global KV channel currents (IK) contained (in mM): NaCl 200, K gluconate 50, CaCl2 5, MgCl2 4, 
TTX 0.3, HEPES 10 and D-glucose 10, adjusted to pH 7.4 with 1 M NaOH. The pipette solution 
consisted of (in mM): K gluconate 135, KF 25, NaCl 9, CaCl2 0.1, MgCl2 1, EGTA 1, HEPES 10 
and ATP-Na2 3, adjusted to pH 7.4 with 1 M KOH. 
 
Experiments were rejected if there were large leak currents or currents showed signs of poor 
space clamping. 
 
4.8 Curve fitting and statistical analysis 
Peak current amplitude was analysed offline using AxoGraph X v1.5.3 (Molecular Devices). 
Current amplitudes were normalized against maximal control current amplitude, or maximal 
current amplitude in the presence of 1 µM rSf1a, for all curve-fitted data. All curve-fitting was 
performed using PRISM 6 for Windows (GraphPad Software Inc., San Diego, CA) using 
nonlinear regression and a least-squares method. Comparisons of two sample means were made 
using a paired Student’s t-test. A test was considered to be significant when p < 0.05. All data 
represent the mean ± SEM of n independent experiments. 
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The data for the voltage dependence of channel activation, for all channel types, were fitted using 
the following current-voltage (I-V) formula: 
𝐼 = 𝑔$%& '1 − * ++,-./[(2324.6)/9];< (𝑉 − 𝑉>?@) Eq. 1 
where I is the amplitude of the current at a given test potential V, gmax is the maximal 
conductance, V0.5 is the voltage at half-maximal activation, s is the slope factor and Vrev is the 
apparent reversal potential. 
 
The data for voltage dependence of NaV channel steady-state inactivation (h∞/V) were amplitude 
inverted and fitted using the following Boltzmann equation: 
ℎB = C+,-./	[(2324.6)/E] Eq. 2 
where A is the fraction of control maximal peak INa, V0.5 is the midpoint of inactivation, k is the 
slope factor, and V is the conditioning prepulse potential. 
 
On-rates were determined by fitting timecourse data with the following single exponential 
association function: 
𝑌 = 𝑌G + (𝐴 − 𝑌G) × (1 − exp(−𝐾 × 𝑡)) Eq. 3 
where Y0 is the maximal peak INa, A is the minimum peak INa, K is the rate constant and t is time. 
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Table 1. Structural statistics for ensemble of 20 NMR structures of rSf1a1.  
 
Experimental restraints2 
 Interproton distance restraints 
  Intraresidue      147 
  Sequential     225 
  Medium range (i–j < 5)       58 
  Long range (i–j ³ 5)     134 
 Disulfide-bond restraints         12 
 Dihedral-angle restraints (36 f, 39 y)        75 
 Total number of restraints per residue        13.9 
R.m.s. deviation from mean coordinate structure (Å) 
 All backbone atoms (residues 1–45)  0.80 ± 0.18 
 All heavy atoms (residues 1–45)  1.24 ± 0.19 
 Backbone atoms (residues 4–26,39–45) 0.13 ± 0.03 
 Heavy atoms (residues 4–26,39–45)  0.43 ± 0.06 
Stereochemical quality3 
 Residues in most favored Ramachandran region (%)  82.4 ± 2.4 
 Ramachandran outliers (%)    0.4 ± 0.9 
 Unfavorable sidechain rotamers (%)    6.8 ± 3.1 
 Clashscore, all atoms4    0.0 ± 0.0 
 Overall MolProbity score  1.55 ± 0.18 
 
1All statistics are given as mean ± S.D. 
2Only structurally relevant restraints, as defined by CYANA, are included. 
3According to MolProbity (http://molprobity.biochem.duke.edu). 
4Defined as the number of steric overlaps >0.4 Å per thousand atoms. 
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Figure Legends  
Figure 1: Production and functional analysis of rSf1a. (A) Schematic representation of the 
pLicC-NSB2 vector used for periplasmic expression of rSf1a. The coding region includes a MalE 
signal sequence (MalESS) for periplasmic export, a His6 affinity tag, an MBP fusion tag, and a 
codon-optimized gene encoding rSf1a, with a TEV protease recognition site inserted between the 
MBP and toxin coding regions. The locations of key elements of the vector are shown, including 
the ribosome-binding site (RBS), T7 promoter and lac operator. (B) Primary structure of rSf1a. 
The non-native N-terminal Ser residue is highlighted in grey. Disulfide-bridge connectivities are 
indicated above the sequence. (C) SDS-PAGE gels illustrating different steps in purification of 
rSf1a. Lanes are as follows: M, molecular weight markers; lane 1, E. coli cell extract prior to 
IPTG induction; lane 2, E. coli cell extract after IPTG induction; lane 3, soluble periplasmic 
extract (the His6-MBP-rSf1a fusion protein is evident at ~50 kDa); lane 4, Ni-NTA beads after 
loading the cell lysate; lane 5, eluate resulting from passage of cell lysate through Ni-NTA resin; 
lane 6, eluate from washing Ni-NTA resin with 10 mM imidazole; lane 7, eluate from washing 
Ni-NTA resin with 500 mM imidazole; lane 8, sample after TEV protease cleavage, showing 
complete cleavage of the MBP-Sf1a fusion protein. (D) RP-HPLC chromatogram showing the 
final step in the purification of rSf1a. The arrow denotes the peak corresponding to correctly 
folded recombinant rSf1a. Inset is a MALDI-TOF MS spectrum showing the [M+H]+ ion for the 
purified recombinant toxin (obs. = 5058.25 Da; calc. = 5056.98 Da). (E) Paralytic effects of two 
versions of recombinant Sf1a following injection in sheep blowflies (L. cuprina). nat-Sf1a 
corresponds to the native sequence, while Ser-Sf1a is recombinant toxin with an additional non-
native N-terminal serine residue. Paralysis was determined 24 h after injection. 
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Figure 2: Inhibition of cockroach DUM neuron NaV channels by rSf1a. (A and C) 
Representative superimposed INa traces before (black), and following (grey and shaded), 
application of 1 µM (A) and 10 µM (C) rSf1a. Dotted lines represent zero current. (Ba) pulse 
protocol used to generate INa shown in panel A. (D) Incomplete inhibition of INa by increasing 
concentrations of rSf1a (grey bars) and 1 µM rSf1a-R31A-W33A (open bar). (E) Typical 
timecourse of INa inhibition by 1 µM rSf1a. Data were fitted with Eq. 3. (F) Effects of 
depolarizing post-pulses on dissociation of rSf1a were assessed using 10-ms post-pulses to +140 
mV applied immediately following a test pulse to –10 mV from –90 mV as detailed in panel Bb. 
INa were normalized to peak control INa before (closed circles), and after (open circles), 
application of 1 µM rSf1a. 
 
Figure 3: The effects of rSf1a on the voltage-dependence of NaV gating in cockroach DUM 
neurons. (A-B) Voltage protocols used to generate INa. (C-D) Typical superimposed families of 
INa are shown before (C), and after (D), application of 1 µM rSf1a. Currents were generated using 
the test pulse protocol shown in panel A. (E-F) Normalized INa-V relationships before (closed 
circles), and after (open circles and shaded), application of 1 µM rSf1a generated using the pulse 
protocol in panel B. Data were fitted with Eq. 1 (see Materials and Methods). Currents were 
normalized against maximum peak INa in controls (E) and maximum peak INa (F). (G-H) Effects 
of rSf1a on steady-state NaV channel inactivation (h∞) were determined using a two-pulse 
protocol detailed in panel B. Peak INa recorded during the test pulse before (closed circles), and 
after (open circles and shaded), application of 1 µM rSf1a were normalized to maximum inward 
INa in controls (G) and maximum inward INa (H) and plotted against pre-pulse potential. The h∞-
V curves were fitted with Eq. 2 (see Materials and Methods). 
	 39	
Figure 4: Effects of rSf1a on CaV and KV channel currents in cockroach DUM neurons. (A–D) 
Inhibition of barium currents through cockroach DUM neuron CaV channels by rSf1a. (A and B) 
Representative superimposed IBa traces before (black), and following (grey and shaded), 
application of 1 µM rSf1a to M-LVA (A) and HVA (B) channels. Dotted lines represent zero 
current. Currents were generated using the test pulse protocol shown in panel Ca. (D) Normalized 
IBa-V relationships before (closed circles), and after (open circles and shaded), application of 
1 μM rSf1a. Currents were generated using the test pulse protocol shown in panel Cb. 
Normalized IBa-V relationships were fitted using Eq. 2. (E–H) Inhibition of cockroach DUM 
neuron KV channels by rSf1a. (E) Representative superimposed IK traces before (black), and 
following (grey and shaded), application of 1 μM rSf1a. Dotted lines represent zero current. 
Currents were generated using the test pulse protocol shown in panel Fa. (G and H) Normalized 
global IK-V relationships before (closed circles), and after (open circles and shaded), application 
of 1 μM rSf1a on peak (G) and late (H) IK. Currents were generated using the test pulse protocol 
shown in panel Fb and measurements for peak and late current were measured at the circle and 
square (50 ms) shown in panel E, respectively. Normalized IK-V relationships were fitted using 
Eq. 2. 
 
Figure 5: 2D 1H-15N HSQC NMR spectrum of rSf1a acquired at 900 MHz. Sequence-specific 
resonance assignments are indicated. Backbone amide assignments are annotated using the one-
letter amino acid code. Assignments are also shown for the sidechain NH correlations of Trp33, 
the sidechain NH2 groups of the four Asn residues, and the aliased peak from the sidechain of 
Arg31. (Note: numbering according to the native sequence).   
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Figure 6: Three dimensional structure of rSf1a. (A) Ensemble of 20 NMR-derived structures. β-
strands are green, while the disulfide bonds are shown as yellow sticks. The dominant extended 
and largely disordered loop is highlighted in red. (Note: numbering according to the native 
sequence). (B) The ensemble is rotated such that the ICK motif is clearly visible. The ICK ring 
formed by two disulfide bonds is shown in magenta and the third ICK disulfide bond piercing 
this ring is also shown. The remainder of the molecule is made transparent for clarity. (C) 
Overlay of rSf1a (red) with structural homologs tachystatin B (PDB 2DCV; blue) and Aps III 
(PDB 2M36; green). The structures are made transparent while the disulfide bonds are shown as 
solid sticks, illustrating the alignment of the ICK motif. The position of the extra disulfide bond 
that serves as a molecular staple in Sf1a and Aps III is also shown. 	
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